Related Experiment Video
Updated: Oct 4, 2026

Murine Kidney Transplant Technique
Published on: October 20, 2015
Serum cystatin C-immunoglobulin high-molecular-weight complexes in kidney and liver transplant patients
J Hermida1, R Romero, J C Tutor
1Laboratorio Central y Servicio de Nefrología, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
Insights
Serum cystatin C is a reliable marker for kidney function in transplant patients. Studies show no evidence of cystatin C-immunoglobulin complexes affecting its filtration, confirming its accuracy for glomerular filtration rate (GFR) assessment.
Area of Science:
- Nephrology
- Transplantation Immunology
Background:
- Serum cystatin C's reliability in assessing glomerular filtration rate (GFR) in renal transplant patients has been questioned.
- Concerns exist regarding impaired filtration of cystatin C complexed with immunoglobulins, potentially underestimating GFR.
Purpose of the Study:
- To investigate the validity of serum cystatin C as a GFR marker in transplant recipients.
- To determine if cystatin C-immunoglobulin complexes form and impact GFR assessment in these patients.
Main Methods:
- Analyzed serum cystatin C and creatinine levels in kidney and liver transplant patients.
- Measured residual cystatin C after polyethylene glycol (PEG) precipitation to detect macromolecular complexes.
Main Results:
- Residual cystatin C levels were high (70-100%), indicating minimal formation of cystatin C-immunoglobulin complexes.
- No significant correlation was found between residual cystatin C and postoperative time in kidney or liver transplant patients.
Conclusions:
- High molecular weight cystatin C-immunoglobulin complexes do not appear to form in renal or liver transplant patients.
- Serum cystatin C remains a reliable marker for GFR assessment in these patient populations.
Background:
It has been suggested recently that the glomerular filtration rate (GFR) in renal transplant patients is underestimated by serum cystatin C due to an impaired filtration of complexed cystatin C with immunoglobulins. Consequently, serum cystatin C may not be a reliable marker of GFR in these patients. Our study was designed to determine whether this supposition is correct.
Methods:
In 87 serum samples from patients with various kidney diseases, 182 samples from renal transplant patients, and 72 samples from liver transplant patients, the concentrations of cystatin C and creatinine were determined, as well as the residual concentration of cystatin C after precipitation of macromolecules with polyethylene glycol (PEG; 6000 molecular weight).
Results:
The residual concentration of serum cystatin C after precipitation with PEG in all cases was much higher (70 to 100%) than that expected in the case of the existence of cystatin C-immunoglobulin complexes. In the kidney and liver transplant patients, there was no significant correlation between the residual concentration of cystatin C and the postoperative time (r = -0.098).
Conclusions:
The results suggest that in renal or liver transplant patients there is no formation of high molecular weight serum cystatin C-immunoglobulin complexes, regardless of the post-transplant period.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Serum Studies: Renal Function Tests
Nephrotic Syndrome I : Introduction
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...